NCT01504958 Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer Patients Status COMPLETED Phase NA
NCT01503944 A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET) Status COMPLETED Phase PHASE1/PHASE2
NCT01496170 A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1]) Status COMPLETED Phase PHASE1
NCT01492374 Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01485302 Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients Status COMPLETED Phase PHASE1
NCT01482845 A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01481961 Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease Status COMPLETED Phase NA
NCT01481558 Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01478633 Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil Status COMPLETED Phase PHASE4
NCT01478204 A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase N/A
NCT01467726 Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects Status COMPLETED Phase PHASE1
NCT01466088 Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD) Status COMPLETED Phase PHASE2
NCT01465360 Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center Status COMPLETED Phase N/A
NCT01459016 A Non-drug Methods Study in Participants With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01454115 Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163 Status COMPLETED Phase PHASE1
NCT01447719 Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07 Status COMPLETED Phase PHASE3